Search

Boniface N. Nganga

Examiner (ID: 1875, Phone: (571)270-7393 , Office: P/3769 )

Most Active Art Unit
3793
Art Unit(s)
3792, 3769, 3797, 3793, 3762
Total Applications
657
Issued Applications
389
Pending Applications
86
Abandoned Applications
200

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4986231 [patent_doc_number] => 20070152569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'Novel benzo[b]furan derivatives and their use' [patent_app_type] => utility [patent_app_number] => 11/324480 [patent_app_country] => US [patent_app_date] => 2006-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3886 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20070152569.pdf [firstpage_image] =>[orig_patent_app_number] => 11324480 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/324480
Novel benzo[b]furan derivatives and their use Jan 3, 2006 Abandoned
Array ( [id] => 311225 [patent_doc_number] => 07528250 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-05 [patent_title] => 'Chroman derivatives and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/316044 [patent_app_country] => US [patent_app_date] => 2005-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10290 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/528/07528250.pdf [firstpage_image] =>[orig_patent_app_number] => 11316044 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/316044
Chroman derivatives and uses thereof Dec 20, 2005 Issued
Array ( [id] => 5141268 [patent_doc_number] => 20070003484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Hydroxypyridinone derivatives, metal complexes thereof and the use thereof for preparing conjugates with biomolecules' [patent_app_type] => utility [patent_app_number] => 11/312238 [patent_app_country] => US [patent_app_date] => 2005-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27417 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20070003484.pdf [firstpage_image] =>[orig_patent_app_number] => 11312238 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/312238
Hydroxypyridinone derivatives, metal complexes thereof and the use thereof for preparing conjugates with biomolecules Dec 19, 2005 Abandoned
Array ( [id] => 7597595 [patent_doc_number] => 07618982 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-17 [patent_title] => 'Heteroarylpyrrolopyridinones active as kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/311386 [patent_app_country] => US [patent_app_date] => 2005-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18581 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/618/07618982.pdf [firstpage_image] =>[orig_patent_app_number] => 11311386 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/311386
Heteroarylpyrrolopyridinones active as kinase inhibitors Dec 18, 2005 Issued
Array ( [id] => 479369 [patent_doc_number] => 07223874 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-29 [patent_title] => 'Bicyclic tetrahydrofuran lactone derivatives and process for the preparation thereof' [patent_app_type] => utility [patent_app_number] => 11/303125 [patent_app_country] => US [patent_app_date] => 2005-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2152 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/223/07223874.pdf [firstpage_image] =>[orig_patent_app_number] => 11303125 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/303125
Bicyclic tetrahydrofuran lactone derivatives and process for the preparation thereof Dec 14, 2005 Issued
Array ( [id] => 4728044 [patent_doc_number] => 20080207588 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Spiro-Heterocyclic Chromans, Thiochromans and Dihydroquinolines' [patent_app_type] => utility [patent_app_number] => 11/814878 [patent_app_country] => US [patent_app_date] => 2005-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12969 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207588.pdf [firstpage_image] =>[orig_patent_app_number] => 11814878 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/814878
Spiro-Heterocyclic Chromans, Thiochromans and Dihydroquinolines Dec 8, 2005 Abandoned
Array ( [id] => 169137 [patent_doc_number] => 07667054 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-23 [patent_title] => 'Cytotoxic agents comprising new taxanes' [patent_app_type] => utility [patent_app_number] => 11/295294 [patent_app_country] => US [patent_app_date] => 2005-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 16157 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/667/07667054.pdf [firstpage_image] =>[orig_patent_app_number] => 11295294 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/295294
Cytotoxic agents comprising new taxanes Dec 5, 2005 Issued
Array ( [id] => 803308 [patent_doc_number] => 07423012 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-09 [patent_title] => 'Phosphinyloxy, oxime and carboxylic acid derivatives which are useful as carboxypeptidase U inhibitors' [patent_app_type] => utility [patent_app_number] => 11/293060 [patent_app_country] => US [patent_app_date] => 2005-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13979 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/423/07423012.pdf [firstpage_image] =>[orig_patent_app_number] => 11293060 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/293060
Phosphinyloxy, oxime and carboxylic acid derivatives which are useful as carboxypeptidase U inhibitors Dec 1, 2005 Issued
Array ( [id] => 4803623 [patent_doc_number] => 20080015212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-17 [patent_title] => 'Inhibitors Of Akt Activity' [patent_app_type] => utility [patent_app_number] => 11/791418 [patent_app_country] => US [patent_app_date] => 2005-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19256 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20080015212.pdf [firstpage_image] =>[orig_patent_app_number] => 11791418 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/791418
Inhibitors Of Akt Activity Nov 27, 2005 Abandoned
Array ( [id] => 5748472 [patent_doc_number] => 20060111404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Salts of N-[2-({(3R)-1-[trans-4-hydroxy-4-(6-methoxypyridin-3-yl)-cyclohexyl]pyrrolidin-3-yl}amino)-2-oxoethyl]-3-(trifluoromethyl)benzamide' [patent_app_type] => utility [patent_app_number] => 11/284220 [patent_app_country] => US [patent_app_date] => 2005-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9885 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20060111404.pdf [firstpage_image] =>[orig_patent_app_number] => 11284220 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/284220
Salts of N-[2-({(3R)-1-[trans-4-hydroxy-4-(6-methoxypyridin-3-yl)-cyclohexyl]pyrrolidin-3-yl}amino)-2-oxoethyl]-3-(trifluoromethyl)benzamide Nov 20, 2005 Abandoned
Array ( [id] => 5776344 [patent_doc_number] => 20060104984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Methods and compositions for use in treating cancer' [patent_app_type] => utility [patent_app_number] => 11/282505 [patent_app_country] => US [patent_app_date] => 2005-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2908 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20060104984.pdf [firstpage_image] =>[orig_patent_app_number] => 11282505 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/282505
Methods and compositions for use in treating cancer Nov 17, 2005 Issued
Array ( [id] => 5851807 [patent_doc_number] => 20060234998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Compositions and methods for treating CNS disorders' [patent_app_type] => utility [patent_app_number] => 11/271019 [patent_app_country] => US [patent_app_date] => 2005-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11556 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20060234998.pdf [firstpage_image] =>[orig_patent_app_number] => 11271019 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/271019
Compositions and methods for treating CNS disorders Nov 9, 2005 Issued
Array ( [id] => 112822 [patent_doc_number] => 07713998 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-11 [patent_title] => 'Nitrogenous heterocyclic compound and pharmaceutical use thereof' [patent_app_type] => utility [patent_app_number] => 11/719058 [patent_app_country] => US [patent_app_date] => 2005-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40690 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/713/07713998.pdf [firstpage_image] =>[orig_patent_app_number] => 11719058 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/719058
Nitrogenous heterocyclic compound and pharmaceutical use thereof Nov 8, 2005 Issued
Array ( [id] => 5866318 [patent_doc_number] => 20060100449 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Integrated two-step process for the production of gamma-methyl-alpha-methylene-gamma-butyrolactone from levulinic acid and hydrogen' [patent_app_type] => utility [patent_app_number] => 11/270038 [patent_app_country] => US [patent_app_date] => 2005-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2847 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20060100449.pdf [firstpage_image] =>[orig_patent_app_number] => 11270038 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/270038
Integrated two-step process for the production of gamma-methyl-alpha-methylene-gamma-butyrolactone from levulinic acid and hydrogen Nov 8, 2005 Abandoned
Array ( [id] => 5866316 [patent_doc_number] => 20060100447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Process for the production of y-methyl-a-methylene-y-butyrolactone from reaction of levulinic acid and hydrogen with recycle of unreacted levulinic acid followed by reaction of crude y-valerolactone and formaldehyde, both reactions being carried out in the supercritical or near-critical fluid phase' [patent_app_type] => utility [patent_app_number] => 11/270011 [patent_app_country] => US [patent_app_date] => 2005-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4577 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20060100447.pdf [firstpage_image] =>[orig_patent_app_number] => 11270011 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/270011
Process for the production of y-methyl-a-methylene-y-butyrolactone from reaction of levulinic acid and hydrogen with recycle of unreacted levulinic acid followed by reaction of crude y-valerolactone and formaldehyde, both reactions being carried out in the supercritical or near-critical fluid phase Nov 8, 2005 Abandoned
Array ( [id] => 5866317 [patent_doc_number] => 20060100448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Process for the production of Y-methyl-A-methylene-Y-butyrolactone from reaction of levulinic acid and hydrogen in the liquid phase followed by reaction of crude-Y-valerolactone and formaldehyde' [patent_app_type] => utility [patent_app_number] => 11/270128 [patent_app_country] => US [patent_app_date] => 2005-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4420 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20060100448.pdf [firstpage_image] =>[orig_patent_app_number] => 11270128 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/270128
Process for the production of Y-methyl-A-methylene-Y-butyrolactone from reaction of levulinic acid and hydrogen in the liquid phase followed by reaction of crude-Y-valerolactone and formaldehyde Nov 8, 2005 Abandoned
Array ( [id] => 4833955 [patent_doc_number] => 20080132502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => '5-Heteroaryl Thiazoles And Their Use As PI3K Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/667064 [patent_app_country] => US [patent_app_date] => 2005-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 65121 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20080132502.pdf [firstpage_image] =>[orig_patent_app_number] => 11667064 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/667064
5-heteroaryl thiazoles and their use as PI3K inhibitors Nov 6, 2005 Issued
Array ( [id] => 5638152 [patent_doc_number] => 20060069126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Pharmaceutically active isoindoline derivatives' [patent_app_type] => utility [patent_app_number] => 11/267607 [patent_app_country] => US [patent_app_date] => 2005-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8865 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20060069126.pdf [firstpage_image] =>[orig_patent_app_number] => 11267607 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/267607
Methods for treating cancer using 3-[1,3dioxo-4-benzamidoisoindolin-2-yl]-2,6-dioxo-5-hydroxypiperidine Nov 3, 2005 Issued
Array ( [id] => 260059 [patent_doc_number] => 07572785 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-11 [patent_title] => 'Substituted imidazoles as cannabinoid receptor modulators' [patent_app_type] => utility [patent_app_number] => 11/265850 [patent_app_country] => US [patent_app_date] => 2005-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23752 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/572/07572785.pdf [firstpage_image] =>[orig_patent_app_number] => 11265850 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/265850
Substituted imidazoles as cannabinoid receptor modulators Nov 2, 2005 Issued
Array ( [id] => 4516625 [patent_doc_number] => 07932394 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-26 [patent_title] => 'Aryloxy-substituted benzimidazole derivatives' [patent_app_type] => utility [patent_app_number] => 11/666555 [patent_app_country] => US [patent_app_date] => 2005-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 75224 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/932/07932394.pdf [firstpage_image] =>[orig_patent_app_number] => 11666555 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/666555
Aryloxy-substituted benzimidazole derivatives Oct 31, 2005 Issued
Menu